Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-1301 in participants with dyslipidemia
NCT07229937Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Nov 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-1301 in dyslipidemia, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Nov 2025; status: recruiting.
02
Drugs
HRS-1301
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07229937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229937.